USPTO serial 79304829
CLOSED LOOP MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- CLARK, ROBERT C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CLOSED LOOP MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard S. Finkelstein
Richard S. Finkelstein RC Trademark Company, LLCP.O. Box 940Brookfield, CT 06804UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; Medical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; pain relief medication; medicines for the treatment of sleep disturbance; medicines for the treatment of hypertension; medicines for the treatment of metabolic disorders | ACTIVE | — |
| 009 | Downloadable computer software for facilitating optimisation of drug dosage and patient instruction; Downloadable communication software for providing access to the Internet; Downloadable software for data processing; Downloadable computer application software for mobile phones, portable media players, handheld computers, namely, software for facilitating optimisation of drug dosage and patient instruction; Downloadable cloud-computing software for deploying virtual machines to a cloud computing platform, managing virtual machines on a cloud computing platform; ; Downloadable interface software for facilitating optimisation of drug dosage and patient instruction; Downloadable application programming interface (API) software; Downloadable computer application software for mobile phones, namely, software for facilitating dose optimisation and patient instruction; Downloadable mobile applications for facilitating optimisation of drug dosage and patient instruction; Downloadable computer software using artificial intelligence for use in software development, machine learning, facial and speech recognition for facilitating optimisation of drug dosage and patient instruction; humanoid robots with artificial intelligence; cloud computing software; RAM (random access memory) card; Computer programs, recorded, for facilitating optimisation of drug dosage and patient instruction; Downloadable computer software using artificial intelligence for data analysis; Downloadable computer software using artificial intelligence for facilitating optimisation of drug dosage and patient instruction; Downloadable computer software for machine learning; computer hardware; data processing apparatus; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; wearable activity trackers; parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely blood pressure monitor, thermometers for medical use, thermometers for medical purposes; Medical diagnostic apparatus for testing testing urine sulfatoxymelatonin levels, saliva cortisol levels, blood sugar levels; Apparatus, instruments and devices for measuring, monitoring and recording body vital health parameters, namely, body composition analyzers for medical purposes, heart rate monitors, blood pressure monitors, and pulse oximeters; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Electronic temperature monitors for medical use; Electronic monitors for medical use for oximetry measurement, sleep monitors, cough characteristic monitors, blood pressure, heart rate, temperature sensors.; parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing in the field of healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; Scientific research in the field of healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; scientific research relating to medicine; scientific research relating to pharmaceuticals; research and development services relating to medicine; research and development services relating to pharmaceuticals; research and development services relating to drugs; research and development services relating to healthcare; providing medical and scientific research information in the field of pharmaceuticals and medicine; Providing scientific information in the field of healthcare, pharmaceutical drugs, drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; Software as a service (SAAS) services featuring software for the collection, management and processing of data and multimedia files and communication in the field of healthcare, pharmaceutical drugs; Platform as a service (PAAS) featuring computer software platforms for the collection, management and processing of data and multimedia files and communication in the field of healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; data-as-a-service (DAAS) services featuring software for the collection, management and processing of data and multimedia files and communication in the field of healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; providing information and data relating to scientific and technological research and development, namely, scientific research, analysis, testing in the field of healthcare, pharmaceutical drugs, drug or digital therapeutic optimisation, clinical pathway optimisation and reimbursement strategies; design and development of computer software; updating and maintenance of computer software; Computer programming in the medical field; Compiling data for research purposes in the field of medical science and medical consultancy; information and advisory related to all of the aforesaid services | ACTIVE | — |
| 044 | Healthcare; health consultancy; healthcare services; healthcare information services; healthcare advisory services; health clinical services; Health screening services in the field of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; medical health assessment services; physical therapy services; Medical monitoring services; individual medical counseling services provided to patients; medical care services relating to patient treatment; health counselling; Health screening services in the field of sleep disorders, hypertension, chronic pain and metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; Providing medical information to patients, medical professionals in the form of reports in the field of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; providing medical information; information and advisory related to all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CLOSED LOOP MEDICINE LTD
- Other trademarks owned by CLOSED LOOP MEDICINE LTD
- Other trademarks owned by CLOSED LOOP MEDICINE LTD
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CLOSED LOOP MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 1, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 8, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 7, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 6, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 16, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 16, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 16, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 15, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 15, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 9, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 1, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |